share_log

Belgravia Hartford Capital Inc. Provides Corporate Update

Belgravia Hartford Capital Inc. Provides Corporate Update

貝爾格拉維亞哈特福德資本公司提供企業更新
newsfile ·  08/15 08:34

Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - BELGRAVIA HARTFORD CAPITAL INC. (CSE: BLGV) ("Belgravia Hartford", "Belgravia" or the "Company") is pleased to announce the appointment of Ms. Ava Tahmasebi as an independent director to the Board of the Company. Additionally, Dr. Shoaib Sheikh has been appointed as head of the company's advisory committee.

安大略省多倫多-(資訊公司-2024年8月15日)-BELGRAVIA HARTFORD CAPITAL INC。(CSE: BLGV)(「Belgravia Hartford」,「Belgravia」或「公司」)很高興地宣佈任命Ms. Ava Tahmasebi爲該公司的獨立董事。此外,Dr. Shoaib Sheikh也被任命爲公司諮詢委員會的負責人。

Ms. Ava Tahmasebi is a seasoned executive with over a decade of experience in driving innovation and business growth within the startup ecosystem. She holds a Doctor of Philosophy (Ph.D.) in Wireless Networks and has recently updated her skills through a Data Analytics program at the University of Toronto. Ms. Tahmasebi has played a pivotal role in mentoring over 50 startups, steering them towards notable success. As CEO of Startup Station, a Toronto-based startup studio with a focus on women entrepreneurs, she has refined her expertise in transforming nascent ideas into successful, market-ready businesses. Startup Station is a member of the National Angel Capital Organization (NACO).

Ava Tahmasebi女士是一名經驗豐富的高管,擁有十多年的創業生態系統創新和業務增長經驗。她擁有無線網絡的哲學博士學位,並最近通過多倫多大學的數據分析計劃更新了她的技能。Tahmasebi女士在指導50多個初創企業方面發揮了關鍵作用,引導它們取得了顯着的成功。作爲位於多倫多的Startup Station的首席執行官,該公司專注於女性企業家,她在將新生的想法轉化爲成功的市場就緒業務方面提高了她的專業知識。Startup Station是National Angel Capital組織(NACO)的成員。

Dr. Shoaib Sheikh, MD, FACS, is a surgeon who has served on multiple provincial, national and international boards and committees for the past 17 years. The nature of involvement has been from board of directors, executive committees, editorial boards and provincial review committees. Dr. Sheikh has served for two full terms on the Board of Governors of the American College of Surgeons which has 90,000 member surgeons and has served on the finance committee of the College of Surgeons. Dr. Shiekh also owns 8,414,095 common shares of Belgravia Hartford which represents 12.49% of the outstanding common shares of the Company.

Shoaib Sheikh醫學博士,FACS,是一名外科醫生,服務於多個省級、國家和國際委員會。參與性質涉及董事會、執行委員會、編輯委員會和省級審查委員會。Sheikh醫生在美國外科醫生學院的董事會上連任兩屆,該醫院擁有9萬名會員外科醫生,並曾在外科醫院的財務委員會任職。Shiekh醫生還擁有Belgravia Hartford的8414095股普通股,佔公司流通普通股的12.49%。

Mr. Mehdi Azodi, The CEO & President of Belgravia stated "The addition of Ms. Tahmasebi to the board strengthens the governance and adds fresh perspective on future investments and due diligence process. The appointment of Dr. Sheikh provides the board and legal team with global business experience and access to capital injection for the company to build out a new business platform and fund the company's litigation affairs."

Belgravia的CEO和總裁Mehdi Azodi表示:「任命Tahmasebi女士加強了公司的治理,併爲未來的投資和盡職調查流程提供了新的視角。任命Sheikh博士爲董事會提供了全球商業經驗和向公司注入資本以建立新業務平台和資助公司訴訟事務的途徑。」

About Belgravia Hartford

關於Belgravia Hartford

Belgravia Hartford Capital Inc. ("Belgravia" or the "Company") is a publicly traded investment holding company listed on the Canadian Securities Exchange. Belgravia is focused on growing its assets and holdings and increasing its net asset value (NAV). Belgravia invests in a portfolio of private and public companies located in jurisdictions governed by the rule of law. It takes a multi-sector investment approach with emphasis in the resources and commodities sector. Belgravia and its investments are considered high risk holdings and it may expose shareholders to significant volatility and losses.

Belgravia Hartford Capital Inc.(「Belgravia」或「公司」)是一家在加拿大證券交易所上市的公共投資控股公司。Belgravia專注於增長其資產和持股,並增加其淨資產價值(NAV)。Belgravia在受法治管轄的地區的私人和公共公司組合中採取多部門投資方法,重點放在資源和商品領域。Belgravia及其投資被認爲是高風險持股,可能使股東面臨重大波動和損失。

For more information, please visit

有關更多信息,請訪問

Forward-Looking Statements

前瞻性聲明

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements include statements that use forward-looking terminology such as "may", "will", "expect", "anticipate", "believe", "continue", "potential" or the negative thereof or other variations thereof or comparable terminology. Such forward-looking statements include, without limitation, statements regarding planned investment activities & related returns, the timing for completion of research and development activities, the potential value of royalties, and other statements that are not historical facts. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, changes in market trends, the completion, results and timing of research undertaken by the Company, risks associated with resource assets, the impact of general economic conditions, commodity prices, industry conditions, dependence upon regulatory, environmental, and governmental approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

本新聞稿中提供的某些信息可能包含涉及實質性已知和未知風險和不確定性以及可能導致公司實際結果、表現或成果與任何未來結果、表現或成果相差極大的其他因素。前瞻性聲明包括使用前瞻性術語的聲明,如「可能」,「將」,「期望」,「預期」,「相信」,「繼續」,「潛力」或其他變體或可比術語的聲明。這些前瞻性聲明包括但不限於計劃的投資活動及相關收益、完成研究和開發活動的時間、版稅的潛在價值及其他非歷史事實的聲明。這些前瞻性聲明受到衆多風險和不確定性的影響,其中一些風險和不確定性超出了公司的控制範圍,包括但不限於市場趨勢的變化、公司進行研究所涉及的完成、結果和時間、資源資產的風險、一般經濟條件的影響、大宗商品價格、行業條件、對規制、環境和政府批准的依賴以及獲取額外融資的不確定性。讀者被警告,在爲該信息進行準備時使用的假設雖然在準備時被認爲是合理的,但可能被證明是不準確的,因此不應過度依賴前瞻性聲明。

For More Information, Please Contact:
Mehdi Azodi, President & CEO
Belgravia Hartford Capital Inc.
(416) 779-3268
mazodi@blgv.ca

欲了解更多信息,請聯繫Mehdi Azodi,董事長兼首席執行官。
Mehdi Azodi,總裁兼首席執行官
貝爾格拉維亞哈特福德資本公司。
(416) 779-3268
mazodi@blgv.ca

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論